Observation on the Effect of Low Frequency Repetitive Transcranial Magnetic Stimulation Combined with Agomestatin in the Treatment of Post-Stroke Depression Patients
GAO Xue-qin
2022, 40(22):
192-196.
Asbtract
(
115 )
PDF (2023KB)
(
16
)
References |
Related Articles |
Metrics
Objective To investigate the effect of low frequency repetitive transcranial magnetic stimulation combined with agomestatin in the treatment of post-stroke depression patients. Methods A total of 70 patients with post-stroke depression who were admitted to Shuyang Minghe Hospital from January 2020 to December 2021 were prospectively selected and divided into two groups according to the random number table method. The control group was treated with agomestatin alone, while the observation group was treated with low-frequency repetitive transcranial magnetic stimulation on the basis of agomestatin. The effectiveness of treatment,levels of 5-hydroxytryptamine (5-HT), brain-derived neurotrophic factor (BDNF), norepinephrine (NE) and nerve growth factor (NGF) in the two groups were detected, and the quality of life of the two groups was evaluated. Results The effective rate of the observation group was significantly higher than control group (P<0.05). Before treatment, there was no significant difference in the levels of NE, 5-HT, BDNF and NGF between the two groups (P>0.05). After treatment, the levels of NE, 5-HT, BDNF and NGF in the two groups were significantly increased (P<0.05), and the levels of NE, 5-HT, BDNF and NGF in the observation group were significantly higher than those in the control group (P<0.05). Before treatment, there were no significant differences in the scores of activity, language, personality, energy, emotion, thinking, social function, family role, self-care ability, upper limb function, vision and work ability between the two groups (P>0.05). The scores of activity, language, personality, energy, emotion, thinking, social function, family role, self-care ability, upper limb function, vision and work ability of stroke patients were significantly increased (P<0.05). Personality, energy, emotion, thinking, social function, family role, self-care ability, upper limb function, vision and work ability scores were significantly higher than those in the control group (P<0.05). Conclusion Low-frequency repetitive transcranial magnetic stimulation combined with agomestatin has better effect on patients with post-stroke depression, can significantly increase the levels of NE, 5-HT, BDNF and NGF, and improve the quality of life.